Huntingtons Disease Topics
The On-Topic Netowork

Huntingtons Disease > Complement


Complement
Complement
Complement
Complement
Complement

The following information is about Complement.

Complement Defined

A large group of proteins activated in sequence when cells are exposed to a foreign substance. Once activated, they form the membrane attack complex, resulting in the death of cells.

This definition is in context to Huntingtons Disease. See more contextual defintions for Complement.


Navigation: [ 1 2 3 4 5 Next ]

New Data on Medtronic's ENDEAVOR(R) Drug-Eluting Coronary Stent Shows Strong Performance in Complex Patients and ...

Published October 12, 2008, 9:49 am, Centre Daily Times

Medtronic, Inc. (NYSE:MDT), today released new data from the ENDEAVOR clinical program at the Transcatheter Cardiovascular Therapeutics (TCT) meeting that reinforces the consistently strong performance of the company's Endeavor drug-eluting stent (DES) across diverse patient populations affected by coronary artery disease.

Full Story


New Data on Medtronic's ENDEAVOR(R) Drug-Eluting Coronary Stent Shows Strong Performance in Complex Patients and ...

Published October 12, 2008, 9:41 am, Finanzen.net

No description is available for this news story.

Full Story


Potential Innovative Cures And Treatments For Infectious Diseases As A Result Of New Systems Biology Awards

Published October 12, 2008, 7:06 am, Medical News Today

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will award five-year contracts estimated to be up to $68.7 million to establish programs in Systems Biology for Infectious Disease Research at four research institutions.

Full Story


£228,000 Grant Boosts Alzheimer's Study At Queen's, Northern Ireland

Published October 12, 2008, 6:06 am, Medical News Today

A Queen's University Belfast academic has been awarded £228,000 to further his research into how Alzheimer's disease progresses. Dr Stephen Todd who works in the Department of Geriatric Medicine at Queen's, has been announced as the only Beeson Ireland 2008 scholar after a transatlantic panel peer-reviewed his proposal.

Full Story


Kmiec to head MU Institute for Interdisciplinary Research

Published October 11, 2008, 9:09 pm, The Huntington Herald-Dispatch

HUNTINGTON — It wasn’t an easy decision for Eric Kmiec to come to Huntington and be lead researcher for the new Marshall Institute for Interdisciplinary Research.

Full Story


Age Related Macular Degeneration: New Genetic Association Identified

Published October 11, 2008, 3:08 am, Medical News Today

A team of clinicians and scientists at the University of Southampton has identified a major new genetic association with age-related macular degeneration, the most common cause of blindness in developed countries.

Full Story


Article In The Journal Of The American Society Of Hypertension Warns Heart Disease Set To Triple In Obese Teens

Published October 11, 2008, 3:07 am, Medical News Today

A recent paper published in the Journal of the American Society of Hypertension projected that the prevalence of premature coronary heart disease (CHD) in young adulthood will more than triple from five percent to 16 percent for currently obese adolescents when they reach 35 years of age.

Full Story


Complement Govt, business urged

Published October 10, 2008, 11:41 pm, The Herald

HARARE Mayor Mr Muchadeyi Masunda has called on the corporate sector to complement Government efforts and channel resources to developing and maintaining infrastructure in high-density suburbs where the majority of their workers reside.

Full Story


Abbott opens new research lab & pilot plant facility in Ludwigshafen

Published October 10, 2008, 8:49 pm, PharmaBiz

Abbott has opened new development laboratories and a pilot plant facility that will research groundbreaking technologies and test large-scale production of newly developed drug formulations. The expansion is part of Abbott's global drug delivery business, SOLIQS, which is based in Ludwigshafen.

Full Story


Cinryze(TM) Receives FDA Approval for Prophylaxis Against Hereditary Angioedema Attacks

Published October 10, 2008, 2:49 pm, Centre Daily Times

Lev Pharmaceuticals, Inc. (OTCBB: LEVP.OB) today announced that the U.S. Food and Drug Administration (FDA) approved Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency. Cinryze is expected to be commercially available for prophylaxis against HAE later this ...

Full Story


Navigation: [ 1 2 3 4 5 Next ]

Are you looking for additional Huntingtons Disease > Complement news? Try our new "Complement News Focus" area.

Off-site Complement Links, User Submitted

The following links have been collected through user bookmark submission in the Complement category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Wed Oct 8

Mon Oct 6

Sun Oct 5

Wed Sep 24

Tue Sep 23

Sat Sep 13

Wed Sep 10

Tue Sep 9

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Complement. If you would like to find related tags we recommend Tag Patterns > Complement

Off-site Complement Research Links

If you still need additional information on Complement then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Huntingtons Disease

If you know the Huntingtons Disease Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Huntingtons-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a